Correlation Between Unicycive Therapeutics and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Candel Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Candel Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Candel Therapeutics
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Candel is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Candel Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.58 times more return on investment than Candel Therapeutics. However, Unicycive Therapeutics is 1.58 times more volatile than Candel Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Candel Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 91.00 in Unicycive Therapeutics on September 1, 2024 and sell it today you would lose (22.00) from holding Unicycive Therapeutics or give up 24.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Candel Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Candel Therapeutics |
Unicycive Therapeutics and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Candel Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |